GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acerus Pharmaceuticals Corp (TSX:ASP) » Definitions » Cash Receipts from Loans

Acerus Pharmaceuticals (TSX:ASP) Cash Receipts from Loans


View and export this data going back to 2009. Start your Free Trial

What is Acerus Pharmaceuticals Cash Receipts from Loans?

Cash Receipts from Loans only applicable to companies reporting Cash Flow from Operations in direct method.


Acerus Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
7025 Langer Drive, Suite 205, Mississauga, ON, CAN, L5N 0E8
Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.
Executives
Samuel Herschkowitz Director
Edward Joseph Gudaitis Director, Senior Officer
Robert Martin Motz Senior Officer
Borys Chabursky Director
John Mark Lievonen Director
Norma Beauchamp Director
Stephen Robert Gregory Director